nm23-H1 protein immunoreactivity in laryngeal carcinoma

Cancer

Volumn 77, Issue 11, 1996, Pages 2246-2250

  Lee, C Soon ^a   Redshaw, Anna ^b   Boag, Guy ^c  

^a ST GEORGE HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c Royal Victorian Eye and Ear Hospital   (Australia)

Author keywords

antimetastatic gene; immunohistochemistry; laryngeal carcinomas; nm23 H1

Indexed keywords

CYTOPLASM PROTEIN; MONOCLONAL ANTIBODY; NUCLEAR PROTEIN; POLYCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; IMMUNOREACTIVITY; LARYNX CARCINOMA; LARYNX PAPILLOMATOSIS; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TISSUE SECTION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; DISEASE PROGRESSION; FEMALE; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; MONOMERIC GTP-BINDING PROTEINS; NEOPLASM PROTEINS; NUCLEOSIDE-DIPHOSPHATE KINASE; POLYPS; PROGNOSIS; SURVIVAL ANALYSIS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; VOCAL CORDS;

EID: 0029898826     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960601)77:11<2246::AID-CNCR10>3.0.CO;2-X     Document Type: Article

References (19)

1. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
2. Steeg PS, Bevilacqua G, Kopper L, Thorgeirsson UP, Talmadge JE, Liotta LA, et al. Evidence for a novel gene associated with low tumour metastatic potential. J Natl Cancer Inst 1988;80(3):200-4.
3. Leone A, McBride OW, Weston A, Wang MG, Anglard P, Cropp CS, et al. Somatic allelic deletion of nm23 in human cancer. Cancer Res 1991;51:2490-3.
4. Bevilacqua G, Sobel ME, Liotta LA, Steeg PS. Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. Cancer Res 1989;49:5185-90.
5. Hennessy C, Henry JA, May FEB, Westly BR, Angus B, Lennard TWJ. Expression of the anti-metastatic gene nm23 in human breast cancer: association with good prognosis. J Natl Cancer Inst 1991;83:281-5.
6. Lee CS, Pirdas-Zivcic A. nm23-H1 protein immunoreactivity in cancers of the gallbladder, extrahepatic bile ducts and ampulla of Vater. Pathology 1994;26:448-52.
7. Cohn KH, Wang F, Desoto-La Paix F, Solomon W, Patterson LG, Arnold MR, et al. Association of nm23-H1 allelic deletions with distant metastases in colorectal carcinoma. Lancet 1991;338:722-4.
8. Barnes R, Masood S, Barker E, Rosengaard AM, Coggin DL, Crowell T, et al. Low nm 23 protein expression in infiltrating ductal breast carcinomas correlates with reduced patient survival. Am J Pathol 1991;139:245-50.
9. Flørenes VA, Aamdal S, Myklebost O, Maelandsmo GM, Bruland OS, Fodstad O. Levels of nm23 messenger RNA in metastatic malignant melanomas: inverse correlation to disease progression. Cancer Res 1992;52:6088-91.
10. Weinberg RA. Oncogenes, anti-oncogenes and the molecular bases of multistep carcinogenesis. Cancer Res 1989;49:3713-21.
11. Wynford-Thomas D. Oncogenes and anti-oncogenes: the molecular basis of tumour behaviour. J Pathol 1991;165:187-201.
12. Matrisian LM, Bowden GT, Krieg P, Furstenberger G, Briand J-P, Leroy P, et al. The mRNA coding for the secreted protease transin is expressed more abundantly in malignant than in benign tumours. Proc Natl Acad Sci USA 1986;83:9413-7.
13. McGregor JM, Yu CCW, Dublin EA, Barnes DM, Levison DA, MacDonald DM. p53 immunoreactivity in human malignant melanoma and dysplastic naevi. Br J Dermatol 1993;128: 606-11.
14. Varesco L, Caligon MA, Simi P, Black DM, Nardini V, Casarino L, et al. The nm23 gene maps to human chromosome band 17q22 and shows a restriction fragment length polymorphism with Bg/II. Genes Chromosom Cancer 1992;4:84-8.
15. Stahl JA, Leone A, Rosengard AM, Porter L, King CR, Steeg P. Identification of a second human nm23 gene, nm23-H2. Cancer Res 1991;51:445-9.
16. Leone A, Flatow U, King CR, Sandeen MA, Margulies IMK, Liotta LA, et al. Reduced tumor incidence, metastatic potential and cytokine responsiveness of nm23-transfected melanoma cells. Cell 1991;65:25-35.
17. Wang L, Patel U, Ghosh L, Chen H-C, Banerjee S. Mutation in the nm23 gene is associated with metastasis in colorectal cancer. Cancer Res 1993;53:717-20.
18. Haut M, Steeg PS, Willson JKV, Markowitz SD. Induction of nm23 gene expression in human colonic neoplasms and equal expression in colon tumors of high and low metastatic potential. J Natl Cancer Inst 1991;83:712-6.
19. Hailat N, Keim DR, Melhem RF, Zhu X, Eckerskom C, Brodeur G, et al. High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification. J Clin Invest 1991;88:341-5.